1,2-dioctanoylglycerol has been researched along with Myeloproliferative Disorders in 1 studies
1,2-dioctanoylglycerol: functions as bioregulator of protein kinase C in human platelets
Myeloproliferative Disorders: Conditions which cause proliferation of hemopoietically active tissue or of tissue which has embryonic hemopoietic potential. They all involve dysregulation of multipotent MYELOID PROGENITOR CELLS, most often caused by a mutation in the JAK2 PROTEIN TYROSINE KINASE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaplan, R | 1 |
| Gabbeta, J | 1 |
| Sun, L | 1 |
| Mao, GF | 1 |
| Rao, AK | 1 |
1 other study available for 1,2-dioctanoylglycerol and Myeloproliferative Disorders
| Article | Year |
|---|---|
Combined defect in membrane expression and activation of platelet GPIIb--IIIa complex without primary sequence abnormalities in myeloproliferative disease.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Aged; Ant | 2000 |